Examine differences between opioids: what the experiments found and how those findings inform discussion of combinations with DXM.
Differences between opioids
Experiments with human transporters show substantial differences between opioids. Tramadol, pethidine, and methadone have serotonergic mechanisms, whereas morphine and hydromorphone did not demonstrate analogous SERT inhibition in the studied system. Fentanyl has a separate clinical serotonergic signal without the same transporter inhibition. Tapentadol inhibited SERT at potentially clinically relevant concentrations and was the most potent NET inhibitor among the tested opioids. The transporter mechanism is well supported; uncertainty concerns the clinical severity of the DXM pair, so its M confidence is High and D remains Low [5].
What the experiment measured
In Rickli’s study, morphine, heroin, oxycodone, codeine, hydrocodone, hydromorphone, and buprenorphine did not inhibit SERT or the norepinephrine transporter (NET). The result concerns SERT and NET inhibition under that laboratory assay’s conditions; effects in vivo may differ [5].
What this means for discussion of DXM combinations
With nonserotonergic opioids, the principal concerns are breathing and consciousness. The assessment rests on pharmacological mechanisms; the extent of their amplification with DXM remains uncertain. There is no basis for relying on DXM to protect against opioid toxicity.
Comparison summary
Experiments with human transporters show substantial differences between opioids.